Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Livia Dézsi, Zoltán Horváth & László Vécsei. (2016) Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1343-1358.
Read now
Read now
Giovanna Vitaliti, Omidreza Tabatabaie, Nassim Matin, Caterina Ledda, Piero Pavone, Riccardo Lubrano, Agostino Serra, Paola Di Mauro, Salvatore Cocuzza & Raffaele Falsaperla. (2015) The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Human Vaccines & Immunotherapeutics 11:12, pages 2749-2763.
Read now
Read now
Nortina Shahrizaila & Nobuhiro Yuki. (2011) The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action. Expert Opinion on Pharmacotherapy 12:10, pages 1551-1560.
Read now
Read now
Judith M Spies & Kazim A Sheikh. (2001) Management of Guillain-Barré syndrome. Expert Review of Neurotherapeutics 1:1, pages 119-129.
Read now
Read now
Sunit C. Singhi, M. Jayshree, Pratibha Singhi, Sanjay Banerjee & S. Prabhakar. (1999) Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome. Annals of Tropical Paediatrics 19:2, pages 167-174.
Read now
Read now
Articles from other publishers (65)
Jinny Tavee, Thomas H. BrannaganIIIIII, Michael W. Lenihan, Sri Muppidi, Liz Kellermeyer & Peter D Donofrio. (2023) Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee. Muscle & Nerve.
Crossref
Crossref
Katsunori Fujii, Tadashi Shiohama, Tomoko Uchida, Hajime Ikehara, Tomoyuki Fukuhara, Daisuke Sawada, Hiromi Aoyama, Hideki Uchikawa, Shoko Yoshii, Yukie Arahata, Naoki Shimojo, Sonoko Misawa & Satoshi Kuwabara. (2023) Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan. Brain and Development 45:1, pages 16-25.
Crossref
Crossref
Jayantee Kalita, Usha K. Misra, Sarvesh K. Chaudhary, Moromi Das, Anadi Mishra, Abhay Ranjan & Mritunjai Kumar. (2022)
Outcome of
Guillain–Barré
syndrome following intravenous immunoglobulin compared to natural course
. European Journal of Neurology 29:10, pages 3071-3080.
Crossref
Crossref
Yusuf A. Rajabally. (2022) Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome. Neurotherapeutics 19:3, pages 885-896.
Crossref
Crossref
Kelsey Satkowiak & A. Gordon Smith. 2021. Emergency Neurology. Emergency Neurology
225
250
.
Jacques Reynolds & George Sachs. 2020. Clinical Neuroimmunology. Clinical Neuroimmunology
299
317
.
Jayantee Kalita, Mritunjai Kumar & Usha K. Misra. (2019) Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome*. Pediatric Critical Care Medicine 20:7, pages 652-659.
Crossref
Crossref
Mahesh Kamate, Mayank Detroja & Anuraag Nalla Reddy. (2019) Do All Children with Guillain Barré Syndrome Need Immunotherapy?. The Indian Journal of Pediatrics 86:5, pages 479-479.
Crossref
Crossref
S. S. Nikitin & L. M. Boriskina. (2019) Immunoglobulins in neurological practice: a review of the literature. Neuromuscular Diseases 9:1, pages 32-51.
Crossref
Crossref
Aviva J. Whelan, Abdullah Tolaymat & Shane C. Rainey. (2019) Bumbling, Stumbling, Fumbling: Weakness, Steppage Gait, and Facial Droop in a 3-Year-Old Male. Global Pediatric Health 6, pages 2333794X1986585.
Crossref
Crossref
W. Köhler, C. G. Bien, S. Ehrlich, J. Faiss, C. Finke, R. Gold, A. Günther, L. Harms, F. Heigl, J. Heine, F. Hoffmann, R. W. C. Janzen, G. J. Jungehülsing, B. Kieseier, I. Kleiter, A. Kraft, F. Paul, H. Prüß, S. Schimrigk, C. Sommer, M. Stettner, C. Trebst & H. Tumani. (2019) Konsensuspapier zum Einsatz der therapeutischen Apherese in der NeurologieConsensus paper on the use of therapeutic apheresis in neurology. DGNeurologie 2:1, pages 15-33.
Crossref
Crossref
Christine Verboon, Pieter A van Doorn & Bart C Jacobs. (2017) Treatment dilemmas in Guillain-Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry 88:4, pages 346-352.
Crossref
Crossref
Elena E. Perez, Jordan S. Orange, Francisco Bonilla, Javier Chinen, Ivan K. Chinn, Morna Dorsey, Yehia El-Gamal, Terry O. Harville, Elham Hossny, Bruce Mazer, Robert Nelson, Elizabeth Secord, Stanley C. Jordan, E. Richard Stiehm, Ashley A. Vo & Mark Ballow. (2017) Update on the use of immunoglobulin in human disease: A review of evidence. Journal of Allergy and Clinical Immunology 139:3, pages S1-S46.
Crossref
Crossref
R. Ts. Bembeeva & N. N. Zavadenko. (2015) Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:8, pages 83.
Crossref
Crossref
R. KORINTHENBERG (FEDERFÜHREND)R. GOLD & U. FELDERHOFF-MÜSER. 2015. Leitlinien Kinder- und Jugendmedizin. Leitlinien Kinder- und Jugendmedizin
Q12.1
Q12.12
.
Hugh J. McMillan & Peter B. Kang. 2015. Neuromuscular Disorders of Infancy, Childhood, and Adolescence. Neuromuscular Disorders of Infancy, Childhood, and Adolescence
398
417
.
H. Royden JonesJr.Jr., Padraic J. Grattan-Smith & Monique M. Ryan. 2015. Neuromuscular Disorders of Infancy, Childhood, and Adolescence. Neuromuscular Disorders of Infancy, Childhood, and Adolescence
379
397
.
Richard AC Hughes, Anthony V Swan & Pieter A van Doorn. (2014) Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2019:10.
Crossref
Crossref
Rudolf Korinthenberg & Wolfgang Müller-Felber. 2014. Neuropädiatrie. Neuropädiatrie
359
404
.
Liming Lu, Gaoquan LuoFang Xiao. (2013) A retrospective survey of the quality of reports and their correlates among randomized controlled trials of immunotherapy for Guillain–Barré syndrome. Immunotherapy 5:8, pages 829-836.
Crossref
Crossref
Rudolf Korinthenberg. 2013. Pediatric Neurology Part II. Pediatric Neurology Part II
1157
1162
.
Richard AC Hughes, Anthony V Swan & Pieter A van Doorn. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
John T. Sladky & Stephen Ashwal. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology
1532
1548
.
Noriki Kamihiro, Masamune Higashigawa, Tomohiro Yamamoto, Ayako Yoshino, Keiko Sakata, Yuji Nashida, Tomoaki Maji, Takashi Fujiwara & Masakazu Inoue. (2012) Acute motor-sensory axonal Guillain–Barré syndrome with unilateral facial nerve paralysis after rotavirus gastroenteritis in a 2-year-old boy. Journal of Infection and Chemotherapy 18:1, pages 119-123.
Crossref
Crossref
Mengjing Huan & A. Gordon Smith. 2012. Emergency Neurology. Emergency Neurology
211
234
.
Hugh J. McMillan, Basil T. Darras & Peter B. Kang. (2011) Autoimmune Neuromuscular Disorders in Childhood. Current Treatment Options in Neurology 13:6.
Crossref
Crossref
I. Elovaara, S. Apostolski, P. van Doorn, N. E. Gilhus, A. Hietaharju, J. Honkaniemi, I. N. van Schaik, N. Scolding, P. Soelberg Sørensen & B. Udd. 2011. European Handbook of Neurological Management. European Handbook of Neurological Management
111
127
.
Richard AC Hughes, Anthony V Swan & Pieter A van Doorn. (2011) Cochrane Review: Intravenous immunoglobulin for Guillain‐Barré syndrome. Evidence-Based Child Health: A Cochrane Review Journal 6:4, pages 1176-1231.
Crossref
Crossref
J. B. Winer. (2011) Commentary on ‘Intravenous immunoglobulin for Guillain‐Barré syndrome’. Evidence-Based Child Health: A Cochrane Review Journal 6:4, pages 1234-1235.
Crossref
Crossref
Matthew Harms. (2011) Inpatient Management of Guillain-Barré Syndrome. The Neurohospitalist 1:2, pages 78-84.
Crossref
Crossref
Glenn Lopate & Alan Pestronk. (2011) Inflammatory Demyelinating Neuropathies. Current Treatment Options in Neurology 13:2, pages 131-142.
Crossref
Crossref
George Sachs. 2011. Clinical Neuroimmunology. Clinical Neuroimmunology
349
371
.
Rotem Kedar, Yehuda Shoenfeld & Howard Amital. 2011. Autoimmune Diseases. Autoimmune Diseases
359
374
.
Paul Golumbek. (2010) Pharmacologic Agents for Pediatric Neuroimmune Disorders. Seminars in Pediatric Neurology 17:4, pages 245-253.
Crossref
Crossref
Richard AC Hughes, Anthony V Swan & Pieter A van Doorn. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Anand B. Pithadia & Nimisha Kakadia. (2010) Guillain-Barré syndrome (GBS). Pharmacological Reports 62:2, pages 220-232.
Crossref
Crossref
Peter D. Donofrio, Alan Berger, Thomas H. BrannaganIIIIII, Mark B. Bromberg, James F. Howard, Normal Latov, Adam Quick & Rup Tandan. (2009) Consensus statement: The use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the aanem AD HOC committee. Muscle & Nerve 40:5, pages 890-900.
Crossref
Crossref
R A C Hughes, M C Dalakas, D R Cornblath, N Latov, M E Weksler & N Relkin. (2009) Clinical applications of intravenous immunoglobulins in neurology. Clinical and Experimental Immunology 158:Supplement_1, pages 34-42.
Crossref
Crossref
Helmar C. Lehmann, Gerd Meyer zu Horste, Bernd C. Kieseier & Hans-Peter Hartung. (2009) Review: Pathogenesis and treatment of immune-mediated neuropathies. Therapeutic Advances in Neurological Disorders 2:4, pages 261-281.
Crossref
Crossref
Malcolm Rabie & Yoram Nevo. (2009) Childhood acute and chronic immune-mediated polyradiculoneuropathies. European Journal of Paediatric Neurology 13:3, pages 209-218.
Crossref
Crossref
Rudolf Korinthenberg. 2009. Neurologische Therapie im Kindesalter. Neurologische Therapie im Kindesalter
297
336
.
I. Elovaara, S. Apostolski, P. van Doorn, N. E. Gilhus, A. Hietaharju, J. Honkaniemi, I. N. van Schaik, N. Scolding, P. Soelberg Sørensen & B. Udd. (2008) EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases. European Journal of Neurology 15:9, pages 893-908.
Crossref
Crossref
Sonja I. van Nes, Catharina G. Faber & Ingemar S. J. Merkies. (2008) Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials. Journal of the Peripheral Nervous System 13:2, pages 136-147.
Crossref
Crossref
F. Ortiz-Corredor & M. Peña-Preciado. (2007) Use of immunoglobulin in severe childhood Guillain-Barré syndrome. Acta Neurologica Scandinavica 115:4, pages 289-293.
Crossref
Crossref
Tom Feasby, Brenda Banwell, Timothy Benstead, Vera Bril, Melissa Brouwers, Mark Freedman, Angelika Hahn, Heather Hume, John Freedman, David Pi & Louis Wadsworth. (2007) Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions. Transfusion Medicine Reviews 21, pages S57-S107.
Crossref
Crossref
Juan J. Archelos & Franz Fazekas. (2006) IVIG therapy in neurological disorders of childhood. Journal of Neurology 253:S5, pages v80-v86.
Crossref
Crossref
Richard AC Hughes, Jean Claude Raphaël, Anthony V Swan & Pieter A van Doorn. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Eli Shahar. (2006) Current Therapeutic Options in Severe Guillain-Barre?? Syndrome. Clinical Neuropharmacology 29:1, pages 45-51.
Crossref
Crossref
Michael Benatar. 2006. Neuromuscular Disease. Neuromuscular Disease
185
207
.
Francis J. DiMarioJrJr. (2005) Intravenous Immunoglobulin in the Treatment of Childhood Guillain-Barré Syndrome: A Randomized Trial. Pediatrics 116:1, pages 226-228.
Crossref
Crossref
Rudolf Korinthenberg, Joachim Schessl, Janbernd Kirschner & Jürgen Schulte Mönting. (2005) Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barré Syndrome: A Randomized Trial. Pediatrics 116:1, pages 8-14.
Crossref
Crossref
M.M. Eibl & H.M. Wolf. 2005. Pädiatrische Allergologie und Immunologie. Pädiatrische Allergologie und Immunologie
511
522
.
RAC Hughes, JC Raphaël, AV Swan & PA van Doorn. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
R.A.C. HughesE.F.M. WijdicksR. BarohnE. BensonD.R. CornblathA. F. HahnJ.M. MeythalerR.G. MillerJ.T. SladkyJ.C. Stevens. (2003) Practice parameter: Immunotherapy for Guillain–Barré syndrome. Neurology 61:6, pages 736-740.
Crossref
Crossref
Suzana B. Cecatto, Roberta I. D. Garcia, Kátia S. Costa, Roberta A B. Novais, Ricardo Yoshimura & Priscila B. Rapoport. (2003) Síndrome de Guillain-Barré como complicação de amigdalite aguda. Revista Brasileira de Otorrinolaringologia 69:4, pages 566-569.
Crossref
Crossref
Bryce A. Binstadt, Raif S. Geha & Francisco A. Bonilla. (2003) IgG Fc receptor polymorphisms in human disease: Implications for intravenous immunoglobulin therapy. Journal of Allergy and Clinical Immunology 111:4, pages 697-703.
Crossref
Crossref
Eli Shahar & Maxim Leiderman. (2003) Outcome of Severe Guillain–Barré Syndrome in Children: Comparison Between Untreated Cases Versus Gamma-Globulin Therapy. Clinical Neuropharmacology 26:2, pages 84-87.
Crossref
Crossref
Zakaria Ammache, Adel K. Afifi, Carl Kice Brown & Jun Kimura. (2016) Childhood Guillain-Barré Syndrome: Clinical and Electrophysiologic Features Predictive of Outcome. Journal of Child Neurology 16:7, pages 477-483.
Crossref
Crossref
Franz G. A. van der Meché & Pieter A. van Doorn. (2000) Guillain-barré syndrome. Current Treatment Options in Neurology 2:6, pages 507-516.
Crossref
Crossref
Essam A. R. Ismail, Issa S. Shabani, Mona Badawi, Hala Sanaa, Samir Madi, Asmaa Al-Tawari, Hani Nadi, Mohamed Zaki & Qusai Al-saleh. (2016) An Epidemiologic, Clinical, and Therapeutic Study of Childhood Guillain-Barré Syndrome in Kuwait: Is It Related to the Oral Polio Vaccine?. Journal of Child Neurology 13:10, pages 488-492.
Crossref
Crossref
Brenda L. Y. Wong & Tracy A. Glauser. (2016) Single High-Dose Intravenous Immunoglobulin for Treatment of Pediatric Guillain-Barré Syndrome. Journal of Child Neurology 13:3, pages 146-146.
Crossref
Crossref
Dimitrios I. Zafeiriou, Eleutherios E. Kontopoulos, George S. Katzos, Nikos P. Gombakis & Florence G. Kanakoudi. (1997) Single dose immunoglobulin therapy for childhood Guillain-Barrésyndrome. Brain and Development 19:5, pages 323-325.
Crossref
Crossref
G Kanra, A Ozon, J Vajsar, L Castagna, G Secmeer & H Topaloglu. (1997) Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. European Journal of Paediatric Neurology 1:1, pages 7-12.
Crossref
Crossref
Eli Shahar, Zamir Shorer, Chaim M. Roifman, Yaacov Levi, Natan Brand, Sarit Ravid & E. Gordon Murphy. (1997) Immune globulins are effective in severe pediatric Guillain-Barre syndrome. Pediatric Neurology 16:1, pages 32-36.
Crossref
Crossref
R Korinthenberg & J S Monting. (1996) Natural history and treatment effects in Guillain-Barre syndrome: a multicentre study.. Archives of Disease in Childhood 74:4, pages 281-287.
Crossref
Crossref